DEPLOYDatabase

Robot model

Synchron Stentrode

The Synchron Stentrode is an endovascular brain-computer interface implant that does not require open-brain surgery.

Manufacturer
Synchron
Form factor
biometric
Maturity
pilot
Lifecycle
active
Deployments
5

Overview

The Synchron Stentrode is an endovascular brain-computer interface implant that does not require open-brain surgery. Implanted via the jugular vein, it detects brain signals to enable patients with severe paralysis (ALS) to communicate via thought. The Stentrode has been tested in COMMAND (US) and SWITCH (Australia) clinical trials with no serious device-related adverse events.

Verified vs. claimed

Maturity stage
pilot(Small-scale deployment in controlled or trial conditions.)
Sources on file
View all sources →

Key facts

CEO

Tom Oxley (Founder, neurologist, Mount Sinai)

Total funding

over $345M ($200M Series D 2024, $75M Series C 2022)

Product

Stentrode (endovascular BCI implant, no open-brain surgery)

Clinical trials

COMMAND (US, FDA-approved), SWITCH (Australia, 4 patients)

Safety

No serious device-related adverse events in 6 patients

Target

Patients with severe paralysis (ALS) to communicate via thought

Data & sources

Web sources

1

1 source backing this record.View all →

Pricing

No verified price is on record for Synchron Stentrode. Physical-AI systems are often sold through enterprise contracts or operated as a service rather than at a public list price.

Deployments (5)

Free to use on your site, with a link back to DEPLOY.

Synchron Stentrode on the deployment map

View the global map

Where Synchron Stentrode is verified operating. Explore the deployment map by place and type.

Free to use on your site, with a link back to DEPLOY.

Recent activity

Every change to this record is dated, sourced, and independently verified where marked.

Full change history →

Safety record

No incidents on record for Synchron Stentrode.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Sources (1)

  1. https://evtoday.com/news/synchrons-brain-computer-interface-evaluated-in-command-early-feasibility-study

Mentioned on (3)

Registry pages whose text names Synchron Stentrode.

Common questions

What is Synchron Stentrode?
The Synchron Stentrode is an endovascular brain-computer interface implant that does not require open-brain surgery. Implanted via the jugular vein, it detects brain signals to enable patients with severe paralysis (ALS) to communicate via thought. The Stentrode has been tested in COMMAND (US) and SWITCH (Australia) clinical trials with no serious device-related adverse events.
How much does Synchron Stentrode cost?
Synchron Stentrode's price is not publicly disclosed. DEPLOY has no verified price on record for Synchron Stentrode from Synchron. Physical-AI systems like this are often sold through enterprise contracts or operated as a service rather than at a public list price; check the manufacturer for the latest.
Is Synchron Stentrode actually deployed in the real world?
Yes. Synchron Stentrode is independently verified in real-world operation on the DEPLOY registry, confirmed at named deployment sites with primary sources: not a concept, render, or demo-only.
Who makes Synchron Stentrode?
Synchron Stentrode is made by Synchron, based in New York, NY, USA, founded in 2016.
Where is Synchron Stentrode deployed?
5 verified deployments of Synchron Stentrode are on the DEPLOY registry, including at Pittsburgh, Pennsylvania, USA, Buffalo, New York, USA, New York, New York, USA.
Can you buy Synchron Stentrode?
Synchron Stentrode is in pilot deployments with named customers and is not yet broadly for sale.
What are alternatives to Synchron Stentrode?
On the DEPLOY registry, comparable biometric robots to Synchron Stentrode include Blackrock Neuroport Array, BrainQ Non-Invasive BCI, Neko Body Scan, Neuralink N1 Implant.
How does Synchron Stentrode compare to Blackrock Neuroport Array?
Synchron Stentrode and Blackrock Neuroport Array (Blackrock Neurotech · 5 deployments) are both biometric robots on the DEPLOY registry. Synchron Stentrode has 5 verified deployments on record. Compare both records for specs, safety, deployments, and verified-vs-claimed autonomy.
Is Synchron Stentrode a top biometric?
On DEPLOY's intelligence score, which blends verified deployments, safety, adoption, media, and IP signals, Synchron Stentrode ranks in roughly the top 7% of biometric models tracked by the registry.
What is Synchron Stentrode's maturity stage?
Synchron Stentrode is at the pilot stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Pilot stage means at least one named-customer trial deployment is verified.
Is Synchron Stentrode safe?
Synchron Stentrode has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.
Methodology: Verified · 1 source (no primary) · last reviewed 2026-10-12

Verification posture

Verified

Low confidence

Review state

Stable

Last reviewed 2026-10-12

Maturity + lifecycle

Maturity stage: pilot

Lifecycle: active

Architectural position

Cohort: biometric

Sources by quality tier

1
unclassified
Unclassified source

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Methodology surface for Synchron Stentrode.

Recent coverage

Synchron Stentrode in third-party press